SynthesisDiabetes, obesity & metabolism2018

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment.

F Javier Escalada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.